Reduced Risk Of Heart Attack, Stroke, Death Observed In Long Term Use Of 'Brilinta' From AstraZeneca

March 15, 2015 1:15 PM

7 0

AstraZeneca's new drug Brilinta can significantly reduce the chances of another stroke, heart attack and even death itself after a clinical trial on Saturday.

AstraZeneca's new drug Brilinta can significantly reduce the chances of another stroke, heart attack and even death itself after a clinical trial on Saturday.

Also read: UK PM May's Conservatives hold 11 point lead over Labour: ORB poll

Read more

To category page

Loading...